Nostrum Wants Automatic Ch. 11 Stay Extended To CEO
By Ben Zigterman · November 25, 2024, 2:29 PM EST
Drugmaker Nostrum Laboratories asked a New Jersey bankruptcy judge to extend its Chapter 11 automatic stay to its CEO and its parent company, Nostrum Pharmaceuticals LLC, both of which are nondebtors....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login